TARA Protara Therapeutics
Protara Therapeutics earnings company data as of 4:48 AM ET 10/23
Limited consensus data for this ticker (thin coverage or data-plan limits).
Dates may be company-announced rather than sell-side consensus.
Calendar and recent prints remain the primary lens when available.
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 9 Nov | EPS | — | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by TARA's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $882K sold by 1 insider outside a trading plan
- $125K sold by 1 insider under 10b5-1 plans
-
Jesse Shefferman CEOSale$882K 215,687 shares at $4.09 23% of stakeTraded Jun 29 Filed Jul 1
-
Jacqueline Zummo Chief R&D OfficerPlanned sale$6,124 1,134 shares at $5.40 1.2% of stakeTraded Apr 8 Filed Apr 9
-
Jacqueline Zummo Chief R&D OfficerPlanned sale$119K 22,598 shares at $5.26 19% of stakeTraded Apr 1 Filed Apr 2
Also filed in the last 12 months, not counted as buying or selling: 9 share withholdings for taxes, 6 stock grants, 4 gifts, and 1 option exercise.
SEC filings
Recent issuer filings from EDGAR, 21 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | QUARTERLY REPORT | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 5.02 | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| 424B5 | PROSPECTUS SUPPLEMENT | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | QUARTERLY REPORT | Filing Doc | |
| DEF 14A | PROXY STATEMENT | Filing Doc | |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 7.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-K | ANNUAL REPORT | Filing Doc | |
| 424B7 | PROSPECTUS SUPPLEMENT | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 7.01,8.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 424B7 | PROSPECTUS SUPPLEMENT | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.